Annual CFF
-$10.06 M
-$43.01 M-130.51%
June 30, 2024
Summary
- As of March 10, 2025, BIOX annual cash flow from financing activities is -$10.06 million, with the most recent change of -$43.01 million (-130.51%) on June 30, 2024.
- During the last 3 years, BIOX annual CFF has fallen by -$17.41 million (-236.66%).
- BIOX annual CFF is now -108.57% below its all-time high of $117.38 million, reached on January 1, 2019.
Performance
BIOX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$6.49 M
+$25.28 M+134.50%
December 1, 2024
Summary
- As of March 10, 2025, BIOX quarterly cash flow from financing activities is $6.49 million, with the most recent change of +$25.28 million (+134.50%) on December 1, 2024.
- Over the past year, BIOX quarterly CFF has increased by +$1.16 million (+21.88%).
- BIOX quarterly CFF is now -94.47% below its all-time high of $117.38 million, reached on April 30, 2018.
Performance
BIOX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$3.91 M
+$5.79 M+308.12%
December 1, 2024
Summary
- As of March 10, 2025, BIOX TTM cash flow from financing activities is $3.91 million, with the most recent change of +$5.79 million (+308.12%) on December 1, 2024.
- Over the past year, BIOX TTM CFF has increased by +$13.96 million (+138.87%).
- BIOX TTM CFF is now -96.67% below its all-time high of $117.38 million, reached on April 30, 2018.
Performance
BIOX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
BIOX Cash From Financing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -130.5% | +21.9% | +138.9% |
3 y3 years | -236.7% | -83.9% | -90.7% |
5 y5 years | +62.7% | -83.9% | -90.7% |
BIOX Cash From Financing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -130.5% | at low | -83.9% | +124.0% | -90.7% | +111.4% |
5 y | 5-year | -130.0% | +62.7% | -83.9% | +124.0% | -92.2% | +111.4% |
alltime | all time | -108.6% | +62.7% | -94.5% | +124.0% | -96.7% | +111.4% |
Bioceres Crop Solutions Cash From Financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | - | $6.49 M(-134.5%) | $3.91 M(-308.1%) |
Sep 2024 | - | -$18.80 M(-453.3%) | -$1.88 M(-81.3%) |
Jun 2024 | -$10.06 M(-130.5%) | $5.32 M(-51.2%) | -$10.06 M(-16.6%) |
Mar 2024 | - | $10.90 M(+1460.1%) | -$12.05 M(-64.2%) |
Dec 2023 | - | $698.70 K(-102.6%) | -$33.67 M(-1.7%) |
Sep 2023 | - | -$26.98 M(-911.5%) | -$34.25 M(-203.9%) |
Jun 2023 | $32.95 M(+122.3%) | $3.32 M(-131.0%) | $32.95 M(+5.6%) |
Mar 2023 | - | -$10.71 M(-9044.1%) | $31.22 M(-16.5%) |
Dec 2022 | - | $119.80 K(-99.7%) | $37.39 M(-11.4%) |
Sep 2022 | - | $40.23 M(+2431.3%) | $42.19 M(+184.6%) |
Jun 2022 | $14.82 M(+101.5%) | $1.59 M(-135.0%) | $14.82 M(-266.8%) |
Mar 2022 | - | -$4.54 M(-192.3%) | -$8.89 M(-168.6%) |
Dec 2021 | - | $4.92 M(-61.7%) | $12.96 M(+77.3%) |
Sep 2021 | - | $12.85 M(-158.1%) | $7.31 M(-0.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2021 | $7.36 M(-78.1%) | -$22.12 M(-227.8%) | $7.36 M(-67.7%) |
Mar 2021 | - | $17.30 M(-2482.6%) | $22.76 M(-41.1%) |
Dec 2020 | - | -$726.30 K(-105.6%) | $38.61 M(-22.7%) |
Sep 2020 | - | $12.90 M(-292.0%) | $49.96 M(+49.0%) |
Jun 2020 | $33.53 M(-224.4%) | -$6.72 M(-120.3%) | $33.53 M(-16.7%) |
Mar 2020 | - | $33.16 M(+212.2%) | $40.25 M(+467.5%) |
Dec 2019 | - | $10.62 M(-401.0%) | $7.09 M(-301.0%) |
Sep 2019 | - | -$3.53 M(<-9900.0%) | -$3.53 M(-103.0%) |
Jun 2019 | -$26.95 M(-123.0%) | - | - |
Jan 2019 | $117.38 M(-1222.4%) | $0.00(-100.0%) | $117.38 M(0.0%) |
Oct 2018 | - | -$200.00(<-9900.0%) | $117.38 M(-0.0%) |
Jul 2018 | - | $0.00(-100.0%) | $117.38 M(0.0%) |
Jun 2018 | -$10.46 M | - | - |
Apr 2018 | - | $117.38 M | $117.38 M |
FAQ
- What is Bioceres Crop Solutions annual cash flow from financing activities?
- What is the all time high annual CFF for Bioceres Crop Solutions?
- What is Bioceres Crop Solutions annual CFF year-on-year change?
- What is Bioceres Crop Solutions quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Bioceres Crop Solutions?
- What is Bioceres Crop Solutions quarterly CFF year-on-year change?
- What is Bioceres Crop Solutions TTM cash flow from financing activities?
- What is the all time high TTM CFF for Bioceres Crop Solutions?
- What is Bioceres Crop Solutions TTM CFF year-on-year change?
What is Bioceres Crop Solutions annual cash flow from financing activities?
The current annual CFF of BIOX is -$10.06 M
What is the all time high annual CFF for Bioceres Crop Solutions?
Bioceres Crop Solutions all-time high annual cash flow from financing activities is $117.38 M
What is Bioceres Crop Solutions annual CFF year-on-year change?
Over the past year, BIOX annual cash flow from financing activities has changed by -$43.01 M (-130.51%)
What is Bioceres Crop Solutions quarterly cash flow from financing activities?
The current quarterly CFF of BIOX is $6.49 M
What is the all time high quarterly CFF for Bioceres Crop Solutions?
Bioceres Crop Solutions all-time high quarterly cash flow from financing activities is $117.38 M
What is Bioceres Crop Solutions quarterly CFF year-on-year change?
Over the past year, BIOX quarterly cash flow from financing activities has changed by +$1.16 M (+21.88%)
What is Bioceres Crop Solutions TTM cash flow from financing activities?
The current TTM CFF of BIOX is $3.91 M
What is the all time high TTM CFF for Bioceres Crop Solutions?
Bioceres Crop Solutions all-time high TTM cash flow from financing activities is $117.38 M
What is Bioceres Crop Solutions TTM CFF year-on-year change?
Over the past year, BIOX TTM cash flow from financing activities has changed by +$13.96 M (+138.87%)